MedTrace Logo

The Effect of Using Projector Kaleidoscope and Matching Card on Children's Fear and Physiological Parameters

NCT06090175 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2023-11-27

No results posted yet for this study

Summary

This research was planned as a randomized controlled experimental type to determine the effect of using a projector caleidoscope and matching card on children's fear and physiological parameters in 3-6-year-old children who were administered inhaler medication.

According to the power analysis performed for the sample size, the power of the sample was calculated with the G\*Power 3.1 program in line with the literature. While the amount of Type I error was 0.05 and the power of the test was 0.95 (α= 0.05, 1-β= 0.95), the minimal sample size was calculated as 105 children (35 children in each group). Considering the possible losses from the sample for any reason during the study period, it was planned to increase the number of samples by 10% and include 38 children in the study and control groups. The data of the research will be collected using the following data collection tools; Child Information Form and Fear Rating Scale

Conditions

  • Fear
  • Child, Only
  • Respiratory Disease

Interventions

OTHER

Projector colleyscope group

Projector kaleidoscope will be used in children aged 3-6 who are administered inhaler medication.

OTHER

Matching card group

Matching card will be used in children aged 3-6 who are administered inhaler medication.

Sponsors & Collaborators

  • Tarsus University

    lead OTHER

Principal Investigators

  • Burcu Korkmaz · Tarsus University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2023-11-23
Completion
2023-11-23

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06090175 on ClinicalTrials.gov